HRP20190341T1 - Dijagnosticiranje srčane insuficijencije - Google Patents

Dijagnosticiranje srčane insuficijencije Download PDF

Info

Publication number
HRP20190341T1
HRP20190341T1 HRP20190341TT HRP20190341T HRP20190341T1 HR P20190341 T1 HRP20190341 T1 HR P20190341T1 HR P20190341T T HRP20190341T T HR P20190341TT HR P20190341 T HRP20190341 T HR P20190341T HR P20190341 T1 HRP20190341 T1 HR P20190341T1
Authority
HR
Croatia
Prior art keywords
igfbp2
heart failure
concentration
patient
quantification
Prior art date
Application number
HRP20190341TT
Other languages
English (en)
Croatian (hr)
Inventor
Philippe Rouet
Fatima SMIH-ROUET
Franck Desmoulin
Michel Galinier
Original Assignee
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Université Paul Sabatier Toulouse Iii
Centre Hospitalier Universitaire De Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Santé Et De La Recherche Médicale (Inserm), Université Paul Sabatier Toulouse Iii, Centre Hospitalier Universitaire De Toulouse filed Critical Institut National De La Santé Et De La Recherche Médicale (Inserm)
Publication of HRP20190341T1 publication Critical patent/HRP20190341T1/hr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4745Insulin-like growth factor binding protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/4473Arrangements for investigating the separated zones, e.g. localising zones by electric means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/325Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
HRP20190341TT 2012-08-09 2013-08-09 Dijagnosticiranje srčane insuficijencije HRP20190341T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305988 2012-08-09
EP13747847.5A EP2883057B1 (en) 2012-08-09 2013-08-09 Diagnostic of heart failure
PCT/EP2013/066697 WO2014023820A1 (en) 2012-08-09 2013-08-09 Diagnostic of heart failure

Publications (1)

Publication Number Publication Date
HRP20190341T1 true HRP20190341T1 (hr) 2019-05-31

Family

ID=48953397

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190341TT HRP20190341T1 (hr) 2012-08-09 2013-08-09 Dijagnosticiranje srčane insuficijencije

Country Status (16)

Country Link
US (2) US20150219669A1 (enExample)
EP (1) EP2883057B1 (enExample)
JP (2) JP6298054B2 (enExample)
CY (1) CY1121406T1 (enExample)
DK (1) DK2883057T3 (enExample)
ES (1) ES2713098T3 (enExample)
HR (1) HRP20190341T1 (enExample)
HU (1) HUE042708T2 (enExample)
LT (1) LT2883057T (enExample)
PL (1) PL2883057T3 (enExample)
PT (1) PT2883057T (enExample)
RS (1) RS58553B1 (enExample)
SI (1) SI2883057T1 (enExample)
SM (1) SMT201900108T1 (enExample)
TR (1) TR201902555T4 (enExample)
WO (1) WO2014023820A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3004891T (pt) 2013-06-06 2019-05-30 Inst Nat Sante Rech Med Biomarcador de re-hospitalização após uma insuficiência cardíaca
JP7401442B2 (ja) * 2018-01-31 2023-12-19 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規使用
EP4056585A4 (en) * 2019-11-06 2024-03-13 National University Corporation Kagawa University HEART FAILURE MARKER
CN120053474B (zh) * 2025-02-26 2025-12-12 浙江大学 辅酶a在制备心肌细胞铁死亡抑制剂中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183681A1 (en) * 2005-02-14 2006-08-17 Bio-Rad Laboratories, Inc. Stabilized compositions containing natriuretic peptides
JP4465469B2 (ja) * 2005-02-21 2010-05-19 国立大学法人佐賀大学 循環器病マーカーとしてのインターロイキン13
EP1722232A1 (en) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
US20080166734A1 (en) * 2005-12-21 2008-07-10 David Xing-Fei Deng Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease
ATE537450T1 (de) * 2006-06-30 2011-12-15 Schering Corp Igfbp2-biomarker
CN101636656A (zh) * 2007-01-25 2010-01-27 霍夫曼-拉罗奇有限公司 Igfbp-7在心力衰竭评估中的用途
EP2310860A1 (en) * 2008-07-30 2011-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure
ES2653646T3 (es) * 2010-07-14 2018-02-08 Vision Tech Bio Pty Ltd Diagnóstico para cáncer colorrectal
CA2807213C (en) * 2010-08-26 2022-06-28 F. Hoffman-La Roche Ag Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
WO2013163345A1 (en) 2012-04-24 2013-10-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
US20140206632A1 (en) * 2013-01-22 2014-07-24 Singulex, Inc. Endothelin in the Diagnosis of Cardiac Disease

Also Published As

Publication number Publication date
DK2883057T3 (en) 2019-03-18
SMT201900108T1 (it) 2019-05-10
EP2883057A1 (en) 2015-06-17
JP2015528562A (ja) 2015-09-28
JP6298054B2 (ja) 2018-03-20
CY1121406T1 (el) 2020-05-29
EP2883057B1 (en) 2018-12-05
US11061037B2 (en) 2021-07-13
JP6595641B2 (ja) 2019-10-23
PL2883057T3 (pl) 2019-07-31
US20180143208A1 (en) 2018-05-24
JP2018109640A (ja) 2018-07-12
TR201902555T4 (tr) 2019-03-21
ES2713098T3 (es) 2019-05-17
US20150219669A1 (en) 2015-08-06
LT2883057T (lt) 2019-04-25
SI2883057T1 (sl) 2019-07-31
WO2014023820A1 (en) 2014-02-13
HUE042708T2 (hu) 2019-07-29
RS58553B1 (sr) 2019-05-31
PT2883057T (pt) 2019-03-06

Similar Documents

Publication Publication Date Title
Vashist et al. Bioanalytical advances in assays for C-reactive protein
Abdel-Khalik et al. Simultaneous determination of endogenous steroid hormones in human and animal plasma and serum by liquid or gas chromatography coupled to tandem mass spectrometry
HRP20190341T1 (hr) Dijagnosticiranje srčane insuficijencije
JP2013533977A5 (enExample)
BR112014016313A2 (pt) medições precisas de analito para tira de teste eletroquímico com base em característica(s) física(s) detectada(s) da amostra contendo o analito e parâmetros de biossensores derivados
EP4160210C0 (en) SANDWICH-TYPE ASSAYS USING DECREASING SIGNAL PORTIONS OF DOSE RESPONSE CURVE TO MEASURE ANALYTES, INCLUDING HIGH-CONCENTRATION ANALYTES
ATE373827T1 (de) Kombination von markern für diabetes typ 1 und 2
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
EP2579043A4 (en) DETECTION METHOD
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
EP3751283A3 (en) Blood-based screen for detecting neurological diseases in primary care settings
JP2013511735A5 (enExample)
WO2009152269A3 (en) Methods of quantifying biomarkers
WO2015031676A3 (en) Integrity testing of hair samples
DE602005001299D1 (de) Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
WO2014140974A3 (en) System and method for determining risk of diabetes based on biochemical marker analysis
JP2012521551A5 (enExample)
JP2015528562A5 (enExample)
JP2019531261A5 (enExample)
Geffen et al. Chemical analysis of otoliths: cross validation between techniques and laboratories
IN2014DN08430A (enExample)
WO2013167727A3 (en) Method for determining arthritis relapse risk
JP2014048126A5 (enExample)
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
HRP20190801T1 (hr) Biološki biljeg za rehospitalizaciju nakon srčane insuficijencije